Emerging therapeutic opportunities for skeletal restoration

Masanobu Kawai, Ulrike I. Mödder, Sundeep Khosla, Clifford J. Rosen

Research output: Contribution to journalReview articlepeer-review

103 Scopus citations


Osteoporosis, a syndrome characterized by thin bones and fractures, has become more prevalent in both women and men. Established therapies for treating this disorder consist primarily of drugs that prevent bone loss, such as the bisphosphonates and selective oestrogen receptor modulators. Although these drugs have been shown to reduce fractures in randomized trials, there is an urgent need for treatments that could lower fracture risk further without additional adverse effects. The introduction of parathyroid hormone (teriparatide), which significantly increases bone mineral density, albeit for a relatively short duration, raised expectations that drugs that stimulate bone formation might cure osteoporosis. After outlining current approaches for treating osteoporosis, this Review focuses on emerging therapeutic opportunities for osteoporosis that are based on recent insights into skeletal physiology. Such novel strategies offer promise not only for reducing age-related bone loss and the associated risk of fractures but also for restoring bone mineral density to healthy levels.

Original languageEnglish (US)
Pages (from-to)141-156
Number of pages16
JournalNature Reviews Drug Discovery
Issue number2
StatePublished - Feb 2011

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Emerging therapeutic opportunities for skeletal restoration'. Together they form a unique fingerprint.

Cite this